These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31750300)
1. Naphthoquinone Tryptophan Hybrids: A Promising Small Molecule Scaffold for Mitigating Aggregation of Amyloidogenic Proteins and Peptides. Viswanathan GK; Paul A; Gazit E; Segal D Front Cell Dev Biol; 2019; 7():242. PubMed ID: 31750300 [TBL] [Abstract][Full Text] [Related]
2. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids. KrishnaKumar VG; Paul A; Gazit E; Segal D Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706 [TBL] [Abstract][Full Text] [Related]
3. An amyloidogenic hexapeptide from the cataract-associated γD-crystallin is a model for the full-length protein and is inhibited by naphthoquinone-tryptophan hybrids. Abu-Hussien M; Viswanathan GK; Haj E; Paul A; Gazit E; Segal D Int J Biol Macromol; 2020 Aug; 157():424-433. PubMed ID: 32302630 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory Effect of Naphthoquinone-Tryptophan Hybrid towards Aggregation of PAP f39 Semen Amyloid. Viswanathan GK; Mohapatra S; Paul A; Arad E; Jelinek R; Gazit E; Segal D Molecules; 2018 Dec; 23(12):. PubMed ID: 30544943 [TBL] [Abstract][Full Text] [Related]
5. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes. Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646 [TBL] [Abstract][Full Text] [Related]
6. Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity. Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D J Alzheimers Dis; 2016; 51(1):165-78. PubMed ID: 26836184 [TBL] [Abstract][Full Text] [Related]
7. Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity. Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D Neurodegener Dis; 2017; 17(2-3):73-82. PubMed ID: 27760426 [TBL] [Abstract][Full Text] [Related]
8. Generic inhibition of amyloidogenic proteins by two naphthoquinone-tryptophan hybrid molecules. Scherzer-Attali R; Shaltiel-Karyo R; Adalist YH; Segal D; Gazit E Proteins; 2012 Aug; 80(8):1962-73. PubMed ID: 22488522 [TBL] [Abstract][Full Text] [Related]
9. Methylations of tryptophan-modified naphthoquinone affect its inhibitory potential toward Aβ aggregation. Scherzer-Attali R; Convertino M; Pellarin R; Gazit E; Segal D; Caflisch A J Phys Chem B; 2013 Feb; 117(6):1780-9. PubMed ID: 23259849 [TBL] [Abstract][Full Text] [Related]
10. A comprehensive computer simulation insight into inhibitory mechanisms of EGCG and NQTrp ligands on amyloid-beta assemblies as the Alzheimer's disease insignia. Zahraee H; Arab SS; Khoshbin Z; Bozorgmehr MR J Biomol Struct Dyn; 2023 Dec; 41(20):10830-10839. PubMed ID: 36576270 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone-Dopamine hybrid. Paul A; Viswanathan GK; Huber A; Arad E; Engel H; Jelinek R; Gazit E; Segal D FEBS J; 2021 Jul; 288(14):4267-4290. PubMed ID: 33523571 [TBL] [Abstract][Full Text] [Related]
12. Molecular structure of the NQTrp inhibitor with the Alzheimer Aβ1-28 monomer. Tarus B; Nguyen PH; Berthoumieu O; Faller P; Doig AJ; Derreumaux P Eur J Med Chem; 2015 Feb; 91():43-50. PubMed ID: 25011560 [TBL] [Abstract][Full Text] [Related]
13. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases. Kreutzer AG; Nowick JS Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987 [TBL] [Abstract][Full Text] [Related]
14. Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation. Valiente-Gabioud AA; Miotto MC; Chesta ME; Lombardo V; Binolfi A; Fernández CO Acc Chem Res; 2016 May; 49(5):801-8. PubMed ID: 27136297 [TBL] [Abstract][Full Text] [Related]
15. Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of α-Synuclein Amyloids in Parkinson's Disease. Paul A; Zhang BD; Mohapatra S; Li G; Li YM; Gazit E; Segal D Front Mol Biosci; 2019; 6():16. PubMed ID: 30968030 [TBL] [Abstract][Full Text] [Related]
16. Complete phenotypic recovery of an Alzheimer's disease model by a quinone-tryptophan hybrid aggregation inhibitor. Scherzer-Attali R; Pellarin R; Convertino M; Frydman-Marom A; Egoz-Matia N; Peled S; Levy-Sakin M; Shalev DE; Caflisch A; Gazit E; Segal D PLoS One; 2010 Jun; 5(6):e11101. PubMed ID: 20559435 [TBL] [Abstract][Full Text] [Related]
17. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation. Takahashi T; Mihara H Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396 [TBL] [Abstract][Full Text] [Related]
18. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations. Nguyen P; Derreumaux P Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046 [TBL] [Abstract][Full Text] [Related]
19. Tyrosine-Generated Nanostructures Initiate Amyloid Cross-Seeding in Proteins Leading to a Lethal Aggregation Trap. Anand BG; Prajapati KP; Shekhawat DS; Kar K Biochemistry; 2018 Sep; 57(35):5202-5209. PubMed ID: 30080038 [TBL] [Abstract][Full Text] [Related]
20. Characterization of amyloid formation by glucagon-like peptides: role of basic residues in heparin-mediated aggregation. Jha NN; Anoop A; Ranganathan S; Mohite GM; Padinhateeri R; Maji SK Biochemistry; 2013 Dec; 52(49):8800-10. PubMed ID: 24236650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]